Minireviews
World J Hepatol
9(25):1043-1053.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1043
Abstract (1320)
|
Core Tip (1293)
|
Full Article (HTML) (4045)
|
Tables (1-3) (528)
|
Full Article (PDF)-1379K (653)
|
Audio-718K (19)
|
Peer-Review Report-94K (219)
|
Answering Reviewers-128K (230)
|
Received: 05/27/2017
|
Revised: 07/13/2017
|
Accepted: 08/04/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (13760)
|
Similar Articles (392)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
9(25):1054-1063.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1054
Abstract (1382)
|
Core Tip (1154)
|
Full Article (HTML) (4586)
|
Full Article (PDF)-1369K (783)
|
Audio-468K (14)
|
Peer-Review Report-78K (292)
|
Answering Reviewers-64K (243)
|
Received: 01/26/2017
|
Revised: 07/18/2017
|
Accepted: 08/16/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (20)
|
Total Visits (14751)
|
Similar Articles (184)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions

World J Hepatol
9(25):1064-1072.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1064
Abstract (1440)
|
Core Tip (1179)
|
Full Article (HTML) (4973)
|
Figures (1-2) (498)
|
Tables (1-2) (489)
|
Full Article (PDF)-1444K (470)
|
Audio-2584K (21)
|
Peer-Review Report-98K (204)
|
Answering Reviewers-81K (170)
|
Received: 03/16/2017
|
Revised: 05/17/2017
|
Accepted: 07/17/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (18152)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients

World J Hepatol
9(25):1073-1080.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1073
Abstract (1337)
|
Core Tip (1178)
|
Full Article (HTML) (3584)
|
Figures (1-3) (489)
|
Tables (1-2) (499)
|
Full Article (PDF)-1721K (490)
|
Audio-547K (35)
|
Peer-Review Report-82K (186)
|
Answering Reviewers-134K (177)
|
Received: 01/04/2017
|
Revised: 04/29/2017
|
Accepted: 05/24/2017
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (17659)
|
Similar Articles (127)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open